Results 121 to 130 of about 48,590 (264)

Botulinum toxin

Indian Journal of Dermatology, Venereology and Leprology, 2008
openaire   +2 more sources

Pain trajectories in children and adolescents with cerebral palsy: A longitudinal population‐based register study

Developmental Medicine &Child Neurology, EarlyView.
Four pain trajectories were identified in a population‐based register study of 4887 children and adolescents with cerebral palsy: (1) increasing trend, low probability of experiencing pain (20.28%), (2) increasing trend, high probability of experiencing pain (30.30%), (3) decreasing trend (26.85%), and (4) consistently high probability of experiencing ...
May Phyu Sin, Johan Jarl, David L. Roth, Ann I. Alriksson‐Schmidt   +3 more
wiley   +1 more source

Beyond aesthetic outcomes: psychodermatological benefits of botulinum toxin treatment in the upper facial third. A narrative review. [PDF]

Front Psychiatry
Loewen Á, Aranda-Guerrero S, Tajima-Pozo K.   +2 more
europepmc   +1 more source

Neuropathic pain in cerebral palsy and related genetic conditions: A scoping review of prevalence, characteristics, and management

Developmental Medicine &Child Neurology, EarlyView.
Abstract Aim To map existing evidence on neuropathic pain in cerebral palsy (CP) and related genetic conditions, including prevalence, descriptors, assessment methods, and management. Method Following prospective registration, five databases (Ovid MEDLINE, Embase, CINAHL, Web of Science, Google Scholar) were searched in June 2025.
Aayushi Khillan, Sanya Verma, Hannah Yeomans, Karen Bau, Caitlin Doyle, Monica S. Cooper, David J. Amor, Carolyn Berryman, Adrienne Harvey   +8 more
wiley   +1 more source

Iatrogenic botulinum Toxin Type A poisoning with persistent unilateral vocal cord paralysis: a case report and clinical implications. [PDF]

Front Pharmacol
Xiang S, Du Y.
europepmc   +1 more source

Muscle morphology and intramuscular fat after treatment‐as‐usual including botulinum neurotoxin A injections in children with cerebral palsy

Developmental Medicine &Child Neurology, EarlyView.
Normalized muscle volume remained unchanged in all evaluated muscles after the 12‐month treatment‐as‐usual in children with cerebral palsy. Higher intramuscular fat fraction was observed in the medial gastrocnemius, suggesting concurrent intramuscular fat infiltration.
Zhongzheng Wang, Antea Destro, Alexandra Åhblom, Sven Petersson, Ferdinand Von Walden, Eva Pontén, Cecilia Lidbeck, Ruoli Wang   +7 more
wiley   +1 more source

Intervention effects of different brands of botulinum toxin type A on Meige syndrome with anxiety symptoms. [PDF]

Front Neurol
Tang Y, Liu R.
europepmc   +1 more source

Weight loss with atogepant in the long‐term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open‐label, 156‐week extension study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess weight loss with atogepant 60 mg once daily during long‐term treatment of chronic migraine (CM) and episodic migraine (EM) among participants previously failed by two to four classes of conventional oral preventive medications.
Dale S. Bond, Jonathan H. Smith, Alexandra Sinclair, Peter J. Goadsby, Jessica Ailani, Yingyi Liu, Rosa De Abreu Ferreira, Brett Dabruzzo, Joel M. Trugman, B. Lee Peterlin   +9 more
wiley   +1 more source

Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections

JAAD Case Reports, 2022
Daniel J. Kim, PhD, Ian D. Odell, MD, PhD   +1 more
doaj   +1 more source

Response by Chirumbolo to "Rare Localized Adverse Reaction to Botulinum Toxin Type A in a Patient Without Allergic History: A Case Report" by Muner et al. [PDF]

Aesthet Surg J Open Forum
Chirumbolo S.
europepmc   +1 more source